Quality of drug information database research for clinical decision support
- PMID: 21594590
- DOI: 10.1007/s11096-011-9522-1
Quality of drug information database research for clinical decision support
Abstract
This commentary identifies studies that have compared commercially available DI databases, and discusses improvements in study methodology that might better guide clinicians in selecting resources for their practice setting. We also provide suggestions for future direction of research in this area with an eye towards clinical decision support systems (CDSS). The body of comparative research of commercially available DI databases is small, and provides little value to the average clinician when making purchasing decisions. Transparency of study methodology would allow readers to choose a database that best fits their practice needs. Future research must consider how DI resources are imbedded within CDSS, such that the alerts generated by the CDSS are consistent with the primary DI workhorse of the practice site. Cohesion between CDSS and DI resources needs to be a consideration in future DI resource comparative research.
Similar articles
-
[Medical and academic leadership is required for IT support for drugs. The principles of good decision support practice (GDSP) should be followed].Lakartidningen. 2012 Aug 8-21;109(32-33):1398-9. Lakartidningen. 2012. PMID: 22953426 Swedish. No abstract available.
-
[Shortages of IT systems for drugs. Development of independent and quality-assured systems is responsibility of health services].Lakartidningen. 2010 Jan 20-26;107(3):92. Lakartidningen. 2010. PMID: 20225681 Swedish. No abstract available.
-
[Efficient and safe drug therapy requires better IT systems. A survey among the chairmen of the Swedish Drug and Therapeutics Committees reveals shortages].Lakartidningen. 2010 Jan 20-26;107(3):102-5. Lakartidningen. 2010. PMID: 20225683 Swedish. No abstract available.
-
Improving medication-related clinical decision support.Am J Health Syst Pharm. 2018 Feb 15;75(4):239-246. doi: 10.2146/ajhp160830. Am J Health Syst Pharm. 2018. PMID: 29436470 Review.
-
Information needs for making clinical recommendations about potential drug-drug interactions: a synthesis of literature review and interviews.BMC Med Inform Decis Mak. 2017 Feb 22;17(1):21. doi: 10.1186/s12911-017-0419-3. BMC Med Inform Decis Mak. 2017. PMID: 28228132 Free PMC article. Review.
Cited by
-
Drug interaction databases in medical literature: transparency of ownership, funding, classification algorithms, level of documentation, and staff qualifications. A systematic review.Eur J Clin Pharmacol. 2015 Nov;71(11):1397-402. doi: 10.1007/s00228-015-1943-7. Epub 2015 Sep 15. Eur J Clin Pharmacol. 2015. PMID: 26369536
-
CUG-binding protein 1 (CUGBP1) expression and prognosis of brain metastases from non-small cell lung cancer.Thorac Cancer. 2016 Jan;7(1):32-8. doi: 10.1111/1759-7714.12268. Epub 2015 May 21. Thorac Cancer. 2016. PMID: 26816536 Free PMC article.
-
CUG-binding protein 1 (CUGBP1) expression and prognosis of non-small cell lung cancer.Clin Transl Oncol. 2013 Oct;15(10):789-95. doi: 10.1007/s12094-013-1005-5. Epub 2013 Jan 29. Clin Transl Oncol. 2013. PMID: 23359188
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources